劈离式肝移植专家共识

2020-10-30 中华医学会外科学分会 中华肝脏外科手术学电子杂志.2020.9(5):429-434.

随着我国公民逝世后器官捐献来源供肝时代的到来,应用劈离式肝移植(SLT)可以有效扩大供肝来源、减少患者移植等待时间,尤其是解决儿童器官短缺的问题。近年来,国内多个移植中心均不同程度地开展了SLT,疗效

中文标题:

劈离式肝移植专家共识

发布日期:

2020-10-30

简要介绍:

随着我国公民逝世后器官捐献来源供肝时代的到来,应用劈离式肝移植(SLT)可以有效扩大供肝来源、减少患者移植等待时间,尤其是解决儿童器官短缺的问题。近年来,国内多个移植中心均不同程度地开展了SLT,疗效不尽相同。现阶段需结合国际上移植技术先进国家的成熟经验来形成适合我国国情的SLT 共识,以进一步提高SLT 的比例和疗效。本文结合专家经验,从供者及供肝评估,受者的选择标准和供、受者匹配,劈离方式和工具的选择,劈离供肝的血管、胆管分离和分配,SLT 的围手术期处理以及器官分配等方面形成SLT 的专家共识。

下载附件:

(因为版权问题,不支持下载)

评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1050044, encodeId=cd43105004471, content=赞👍<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65f55434449, createdName=ms3000001417265973, createdTime=Mon Sep 13 21:07:10 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902782, encodeId=10d3902e82c2, content=好好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d222471257, createdName=1243a20em71(暂无昵称), createdTime=Fri Nov 27 12:43:50 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898759, encodeId=1108898e59d1, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa95191160, createdName=1471905fm87暂无昵称, createdTime=Thu Nov 12 17:23:45 CST 2020, time=2020-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898478, encodeId=f8fc8984e8db, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b3d5290623, createdName=14861974m47(暂无昵称), createdTime=Wed Nov 11 15:45:10 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898408, encodeId=40d3898408c0, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/d311346c29d641098dff5f23016e7da7/88055690e20d4cfd85ada57636794e93.jpg, createdBy=12875418351, createdName=ms6000001515816393, createdTime=Wed Nov 11 09:25:05 CST 2020, time=2020-11-11, status=1, ipAttribution=)]
    2021-09-13 ms3000001417265973

    赞👍#学习#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1050044, encodeId=cd43105004471, content=赞👍<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65f55434449, createdName=ms3000001417265973, createdTime=Mon Sep 13 21:07:10 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902782, encodeId=10d3902e82c2, content=好好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d222471257, createdName=1243a20em71(暂无昵称), createdTime=Fri Nov 27 12:43:50 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898759, encodeId=1108898e59d1, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa95191160, createdName=1471905fm87暂无昵称, createdTime=Thu Nov 12 17:23:45 CST 2020, time=2020-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898478, encodeId=f8fc8984e8db, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b3d5290623, createdName=14861974m47(暂无昵称), createdTime=Wed Nov 11 15:45:10 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898408, encodeId=40d3898408c0, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/d311346c29d641098dff5f23016e7da7/88055690e20d4cfd85ada57636794e93.jpg, createdBy=12875418351, createdName=ms6000001515816393, createdTime=Wed Nov 11 09:25:05 CST 2020, time=2020-11-11, status=1, ipAttribution=)]
    2020-11-27 1243a20em71(暂无昵称)

    好好好学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1050044, encodeId=cd43105004471, content=赞👍<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65f55434449, createdName=ms3000001417265973, createdTime=Mon Sep 13 21:07:10 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902782, encodeId=10d3902e82c2, content=好好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d222471257, createdName=1243a20em71(暂无昵称), createdTime=Fri Nov 27 12:43:50 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898759, encodeId=1108898e59d1, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa95191160, createdName=1471905fm87暂无昵称, createdTime=Thu Nov 12 17:23:45 CST 2020, time=2020-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898478, encodeId=f8fc8984e8db, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b3d5290623, createdName=14861974m47(暂无昵称), createdTime=Wed Nov 11 15:45:10 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898408, encodeId=40d3898408c0, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/d311346c29d641098dff5f23016e7da7/88055690e20d4cfd85ada57636794e93.jpg, createdBy=12875418351, createdName=ms6000001515816393, createdTime=Wed Nov 11 09:25:05 CST 2020, time=2020-11-11, status=1, ipAttribution=)]
    2020-11-12 1471905fm87暂无昵称

    赞👍

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1050044, encodeId=cd43105004471, content=赞👍<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65f55434449, createdName=ms3000001417265973, createdTime=Mon Sep 13 21:07:10 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902782, encodeId=10d3902e82c2, content=好好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d222471257, createdName=1243a20em71(暂无昵称), createdTime=Fri Nov 27 12:43:50 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898759, encodeId=1108898e59d1, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa95191160, createdName=1471905fm87暂无昵称, createdTime=Thu Nov 12 17:23:45 CST 2020, time=2020-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898478, encodeId=f8fc8984e8db, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b3d5290623, createdName=14861974m47(暂无昵称), createdTime=Wed Nov 11 15:45:10 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898408, encodeId=40d3898408c0, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/d311346c29d641098dff5f23016e7da7/88055690e20d4cfd85ada57636794e93.jpg, createdBy=12875418351, createdName=ms6000001515816393, createdTime=Wed Nov 11 09:25:05 CST 2020, time=2020-11-11, status=1, ipAttribution=)]
    2020-11-11 14861974m47(暂无昵称)

    赞👍

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1050044, encodeId=cd43105004471, content=赞👍<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65f55434449, createdName=ms3000001417265973, createdTime=Mon Sep 13 21:07:10 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902782, encodeId=10d3902e82c2, content=好好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d222471257, createdName=1243a20em71(暂无昵称), createdTime=Fri Nov 27 12:43:50 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898759, encodeId=1108898e59d1, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa95191160, createdName=1471905fm87暂无昵称, createdTime=Thu Nov 12 17:23:45 CST 2020, time=2020-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898478, encodeId=f8fc8984e8db, content=赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b3d5290623, createdName=14861974m47(暂无昵称), createdTime=Wed Nov 11 15:45:10 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898408, encodeId=40d3898408c0, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/d311346c29d641098dff5f23016e7da7/88055690e20d4cfd85ada57636794e93.jpg, createdBy=12875418351, createdName=ms6000001515816393, createdTime=Wed Nov 11 09:25:05 CST 2020, time=2020-11-11, status=1, ipAttribution=)]
    2020-11-11 ms6000001515816393

    0

拓展阅读

肝移植术后常见病变的病理诊断与分级指南

全国肝胆肿瘤及移植病理协作组 · 2009-11-01

他克莫司在临床肝移植中的应用指南

中华医学会器官移植学分会 · 2010-11-01

2010国际共识会议:肝细胞癌肝移植-专家文本

外国肝病科相关专家小组(统称) · 2010-12-04

2011 肝移植受者肾功能损伤诊疗指南

中华医学会外科学分会器官移植学组 · 2011-08-01

2011 SEMICYUC-SENPE共识 重症患者营养与代谢专业支持指导指南(第六章):肝衰竭与肝移植

西班牙肠外肠内营养学会(SENPE,Spanish Society of Parenteral and Enteral Nutrition) · 2011-12-01

2012BTS 英国移植学会:非酒精性脂肪性肝炎患者的肝移植

英国器官移植学会(BTS,British Transplantation Society) · 2012-04-01